1. Prognostic value of O⁶-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

   • Lucie Karayan-Tapon
   • Véronique Quillien
   • Catherine Gratas-Rabbia-Ré

   Laboratory Investigation - Human/Animal Tissue 20 October 2009 Pages: 311 - 322

   

2. Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells

   • Angel Ayuso-Sacido
   • Jennifer A. Moliterno
   • John A. Boockvar

   Laboratory Investigation - Human/Animal Tissue 24 October 2009 Pages: 323 - 337

   

3. MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells

   • Jung Yeon Lim
   • Ji Hyeon Oh
   • Sin-Soo Jeun

   Laboratory Investigation - Human/Animal Tissue 28 October 2009 Pages: 339 - 346

   

4. Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value

   • Roberto Garcia-Navarrete
   • Esperanza Garcia
   • Julio Sotelo

   Laboratory Investigation - Human/Animal Tissue 25 October 2009 Pages: 347 - 351

   

5. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade

   • Audrey Rousseau
   • Ahmed Idbaih
   • Jean-Yves Delattre

   Laboratory Investigation - Human/Animal Tissue 29 October 2009 Pages: 353 - 364

   

6. Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells

   • Mathieu Provençal
   • Nancy Berger-Thibault
   • Richard Béliveau

   Laboratory Investigation - Human/Animal Tissue 18 November 2009 Pages: 365 - 372

   

7. p53 regulates LIF expression in human medulloblastoma cells

   • Euan W. Baxter
   • Jo Milner

   Laboratory Investigation - Human/Animal Tissue 12 November 2009 Pages: 373 - 382

   

8. Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

   • Rajan Jain
   • Shehanaz Ellika
   • Tom Mikkelsen

   Clinical Study - Patient Study 15 October 2009 Pages: 383 - 388

   

9. Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status

   • Delia Kurzwelly
   • Martin Glas
   • Ulrich Herrlinger

   Clinical Study - Patient Study 20 October 2009 Pages: 389 - 392

   

10. Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy

    • Samina Afzal
    • Diane Wherrett
    • Eric Bouffet

    Clinical Study - Patient Study 10 October 2009 Pages: 393 - 399

    

11. The role of salvage reirradiation for malignant gliomas that progress on bevacizumab

    • Roy G. Torcuator
    • Ravneet Thind
    • Tom Mikkelsen

    Clinical Study - Patient Study 17 October 2009 Pages: 401 - 407

    

12. Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma

    • Kim Kramer
    • Brian H. Kushner
    • Nai-Kong V. Cheung

    Clinical Study - Patient Study 05 November 2009 Pages: 409 - 418

    

13. Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri

    • Benjamin M. Ellingson
    • Scott D. Rand
    • Kathleen M. Schmainda

    Case Report 08 October 2009 Pages: 419 - 423

    

14. Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites

    • R. Ackermann
    • A. Semmler
    • M. Linnebank

    Case Report 11 October 2009 Pages: 425 - 427

    

15. Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue

    • David Buchbinder
    • Moise Danielpour
    • Joseph Lasky

    Case Report Open access 19 November 2009 Pages: 429 - 437

    

16. Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination

    • Maria Grazia Passarin
    • Giuseppe Moretto
    • Rebecca Pedersini

    Case Report 31 October 2009 Pages: 439 - 444

    

17. A surgically treated case of Lhermitte–Duclos disease with a precise natural history and high uptake of FDG on PET

    • Yuko Goto
    • Naoya Hashimoto
    • Toshiki Yoshimine

    Case Report 12 November 2009 Pages: 445 - 450

    

18. Multiple extracranial metastases from secondary glioblastoma multiforme: a case report and review of the literature

    • Li Zhen
    • Cheng Yufeng
    • Xiang Lei

    Case Report 07 November 2009 Pages: 451 - 457

    

19. Erratum to: Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling

    • Watcharin Loilome
    • Avadhut D. Joshi
    • Gregory J. Riggins

    Erratum 11 March 2010 Pages: 459 - 459